1. The Chairman of the Company Behind the EpiPen Made $98 Million in 2016

    The Chairman of the Company Behind the EpiPen Made $98 Million in 2016

    Mylan's chairman Robert Coury made roughly $98 million in 2016, a year in which the company faced criticism for the price of the EpiPen and the stock fell almost 30%, according to company filings.

    On top of that, The Wall Street Journal reported, Coury made $66.3 million in other payments, including retirement benefits, bringing the amount he made in 2016 to $164 million...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned

  3. Authors